Role of the Equilibrative and Concentrative Nucleoside Transporters in the Intestinal Absorption of the Nucleoside Drug, Ribavirin, in Wild-Type and Ent1(−/−) Mice
- 19 July 2012
- journal article
- research article
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 9 (9) , 2442-2449
Abstract
Ribavirin is frontline treatment for hepatitis C virus infection. To determine the role of nucleoside transporters in the intestinal absorption of orally administered ribavirin, we perfused the intestines of Ent1(−/−) and wild-type mice, in situ, with [3H] ribavirin (20, 200, and 5000 μM) in the presence and absence of sodium. The decrease in luminal ribavirin concentration over 30 min was measured at 5 min intervals. Blood samples were collected approximately every 10 min. Ribavirin plus phosphorylated metabolite concentrations (hereafter referred to as ribavirin) were determined in tissue, blood, and plasma by HPLC fractionation and scintillation counting. There was no significant difference between wild-type and Ent1(−/−) mice in intestinal loss of ribavirin at any ribavirin concentration studied. Perfusions without sodium drastically reduced the intestinal loss of ribavirin in both wild-type and Ent1(−/−) mice. After 20 μM ribavirin perfusions, Ent1(−/−) intestinal tissue contained 8-fold greater ribavirin than wild-type mice (p < 0.01). Ribavirin concentrations in the wild-type intestinal tissue were 70-fold higher after 200 vs 20 μM perfusions (p < 0.001), indicating saturation of intestinal ribavirin efflux and possibly other processes as well. Ribavirin plasma concentrations were significantly higher in wild-type mice (2.7-fold) vs Ent1(−/−) mice at 30 min after the 20 μM perfusion (p < 0.01). These results suggest that, at lower intestinal concentrations of ribavirin, concentrative and equilibrative nucleoside transporters are important in the intestinal absorption of ribavirin. At higher intestinal concentrations, these transporters are saturated and other processes in the intestine (transport and/or metabolism) play an important role in the absorption of ribavirin.Keywords
This publication has 37 references indexed in Scilit:
- Treatment of Chronic Hepatitis C Infection with Peginterferons Plus RibavirinSeminars in Liver Disease, 2004
- (Section A: Molecular, Structural, and Cellular Biology of Drug Transporters) Mammalian Nucleoside TransportersCurrent Drug Metabolism, 2004
- Side effects of therapy for chronic hepatitis CGastroenterology, 2003
- Kinetic Modeling of Triamterene Intestinal Absorption and its Inhibition by Folic Acid and MethotrexateJournal of Drug Targeting, 2003
- Pirarubicin is taken up by a uridine-transportable sodium-dependent concentrative nucleoside transporter in Ehrlich ascites carcinoma cellsCancer Chemotherapy and Pharmacology, 2003
- Side effects of therapy of hepatitis C and their managementHepatology, 2002
- The influence of active secretion processes on intestinal absorption of salbutamol in the ratEuropean Journal of Pharmaceutics and Biopharmaceutics, 2001
- Human intestinal es nucleoside transporter: molecular characterization and nucleoside inhibitory profilesCancer Chemotherapy and Pharmacology, 2000
- Evidence of a specialized transport mechanism for the intestinal absorption of baclofenBiopharmaceutics & Drug Disposition, 1989
- Drug Absorption I: An In Situ Rat Gut Technique Yielding Realistic Absorption RatesJournal of Pharmaceutical Sciences, 1969